{"transactions":[{"id":1485393,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-10T21:00:05.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon."}],"balance_after":12800,"derivative":{"exercise_price":1.03,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":12800},"source":{"system":"sec-edgar","filing":"0000950170-24-071396","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024071396/ownership.xml","form_type":"4"}},{"id":1862808,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option\n(right to buy)","published_at":"2023-06-08T21:24:37.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares underlying the option vest in equal monthly installments measured from June 6, 2023, with the first vesting occurring on July 6, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-014920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323014920/doc4.xml","form_type":"4"}},{"id":1917456,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-19T21:00:09.000Z","date":"2023-03-30","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In equal installments on April 30, 2023 and May 30, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":16667,"derivative":{"exercise_price":0.66,"expiration_date":"2033-03-29","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0000899243-23-011453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323011453/doc4.xml","form_type":"4"}},{"id":1917455,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-19T21:00:09.000Z","date":"2023-03-30","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from March 30, 2023, with the first vesting occuring on April 30, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":150000,"derivative":{"exercise_price":0.66,"expiration_date":"2033-03-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-23-011453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323011453/doc4.xml","form_type":"4"}},{"id":2477327,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-10T16:30:23.000Z","date":"2021-12-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":5.21,"expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-069032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919121069032/doc4.xml","form_type":"4"}},{"id":2933161,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-23T17:26:35.000Z","date":"2020-12-22","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option shall vest and become exercisable on December 13, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":28732,"derivative":{"exercise_price":0.74,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000899243-20-035009","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924320035009/doc4.xml","form_type":"4"}},{"id":2933160,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-23T17:26:35.000Z","date":"2020-12-22","kind":"exercise","acquired":true,"shares":7000,"price":0.74,"value":5180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":45850,"source":{"system":"sec-edgar","filing":"0000899243-20-035009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924320035009/doc4.xml","form_type":"4"}},{"id":2948774,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-11T06:11:00.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":76000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":76000,"derivative":{"exercise_price":31.83,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":76000},"source":{"system":"sec-edgar","filing":"0000899243-20-033468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924320033468/doc4.xml","form_type":"4"}},{"id":2981554,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-13T16:08:47.000Z","date":"2020-11-12","kind":"exercise","acquired":false,"shares":10002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option vested and become exercisable on December 13, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":25730,"derivative":{"exercise_price":0.74,"exercise_date":"2017-12-13","expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":10002},"source":{"system":"sec-edgar","filing":"0001209191-20-058274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120058274/doc4.xml","form_type":"4"}},{"id":2981553,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-13T16:08:47.000Z","date":"2020-11-12","kind":"exercise","acquired":false,"shares":9998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and become exercisable on December 7, 2018, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":12348,"derivative":{"exercise_price":0.74,"exercise_date":"2018-12-07","expiration_date":"2027-12-07","underlying":"Common Stock","underlying_shares":9998},"source":{"system":"sec-edgar","filing":"0001209191-20-058274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120058274/doc4.xml","form_type":"4"}},{"id":2981552,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-13T16:08:47.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":10002,"price":25.1,"value":251050.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":38850,"source":{"system":"sec-edgar","filing":"0001209191-20-058274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120058274/doc4.xml","form_type":"4"}},{"id":2981551,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-13T16:08:47.000Z","date":"2020-11-12","kind":"exercise","acquired":true,"shares":10002,"price":0.74,"value":7401.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":48852,"source":{"system":"sec-edgar","filing":"0001209191-20-058274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120058274/doc4.xml","form_type":"4"}},{"id":2981550,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-13T16:08:47.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":9998,"price":25.1,"value":250949.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":38850,"source":{"system":"sec-edgar","filing":"0001209191-20-058274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120058274/doc4.xml","form_type":"4"}},{"id":2981549,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-13T16:08:47.000Z","date":"2020-11-12","kind":"exercise","acquired":true,"shares":9998,"price":0.74,"value":7398.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":48848,"source":{"system":"sec-edgar","filing":"0001209191-20-058274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120058274/doc4.xml","form_type":"4"}},{"id":2996621,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-02T14:00:55.000Z","date":"2020-10-29","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and become exercisable on December 7, 2018, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":22346,"derivative":{"exercise_price":0.74,"exercise_date":"2018-12-07","expiration_date":"2027-12-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-056390","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120056390/doc4.xml","form_type":"4"}},{"id":2996620,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2020-11-02T14:00:55.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":20000,"price":19.1,"value":382000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on by the reporting person."}],"balance_after":38850,"source":{"system":"sec-edgar","filing":"0001209191-20-056390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120056390/doc4.xml","form_type":"4"}},{"id":2996619,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2020-11-02T14:00:55.000Z","date":"2020-10-29","kind":"exercise","acquired":true,"shares":20000,"price":0.74,"value":14800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on by the reporting person."}],"balance_after":58850,"source":{"system":"sec-edgar","filing":"0001209191-20-056390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000120919120056390/doc4.xml","form_type":"4"}},{"id":3334011,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-20T19:23:50.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2021, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":16.1,"expiration_date":"2029-12-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-029838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319029838/doc4.xml","form_type":"4"}},{"id":3556739,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-12T16:06:10.000Z","date":"2019-04-11","kind":"grant","acquired":true,"shares":127512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2020, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":127512,"derivative":{"exercise_price":16.11,"expiration_date":"2029-04-10","underlying":"Common Stock","underlying_shares":127512},"source":{"system":"sec-edgar","filing":"0001750019-19-000021","document":"wf-form4_155509955568771.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000175001919000021/wf-form4_155509955568771.xml","form_type":"4"}}]}